Atlas Trials

Large-cell Lymphoma

12 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Large-cell Lymphoma

RecordFirmDate
NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers (NCT05020678)Nkarta, Inc.2021-08-20
QUILT-3.061: CD19 t-haNK in Subjects With Diffuse Large B-Cell Lymphoma (NCT04052061)ImmunityBio, Inc.2019-09-16
UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep (NCT02722668)Masonic Cancer Center, University of Minnesota2017-05-15
Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies (NCT02991898)Masonic Cancer Center, University of Minnesota2017-02-16
Haploidentical BMT With Post-Transplant Cyclophosphamide and Bendamustine (NCT02996773)University of Arizona2016-11-29
Anti-CD22 Chimeric Receptor T Cells in Pediatric and Young Adults With Recurrent or Refractory CD22-expressing B Cell Malignancies (NCT02315612)National Cancer Institute (NCI)2014-12-12
Anti-CD19 White Blood Cells for Children and Young Adults With B Cell Leukemia or Lymphoma (NCT01593696)National Cancer Institute (NCI)2012-06-29
Safety and Tolerability of HSC835 in Patients With Hematological Malignancies (NCT01474681)Novartis Pharmaceuticals2012-01-09
Study of SGN-30 (Anti-CD30 mAb) in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma (NCT00099255)Seagen Inc.2004-09-01

Track Large-cell Lymphoma automatically

Every clearance here is in the API, with alerts when new ones post.